Latest ArticlesRenal anemia is the common complication of chronic kidney disease (CKD), which causes the decline of renal function and the increased anemia. Anemia can accelerate the progress of CKD and affect the life quality of CKD patients and increase the mortality as well. Anemia is one of independent risk factors in CKD patients with cardiovascular disease. To improve the anemia status of CKD patients is of important clinical significance. This review summarizes the progress in etiology of renal anemia and its diagnosis and treatment.
Multiple myeloma (MM) is a common malignant blood tumor. Meantime, there is still no cure method and its recurrence rate is very high. Panobinostat is a histone deacetylase inhibitor (HDACi), which is used in MM treatment. This review summarizes the panobinostat used in MM treatment including its action mechanism against HDACi and its adverse reactions.
Primary membranous nephropathy (PMN) [or idiopathic membranous nephropathy (IMN)] belongs to one of the most common pathological type of membranous glomerular nephropathy. As the development of anti-phospholipase A2 receptor antibody and anti-thrombospondin type-1 domain-containing 7A antibody for IMN treatment, the new immune-suppressants such as tacrolimus, and monoclonal antibodies such as rituximab have been successively used in IMN treatment. This review describes the recent progress in IMN diagnosis and its treatment.
IgA nephropathy is the most common primary glomerulonephritis. Renal biopsy remains the definitive diagnostic method of IgA nephropathy. Recently, the development of new diagnostic markers and therapeutic drugs provide some new ideas for the diagnosis and treatment of IgA nephropathy. There is still a lack of specific immunosuppressive therapy. This review describes the progress of IgA nephropathy diagnosis and its treatment.
During pregnancy period, the body system of pregnant women has some special adaptive changes including in kidney. However, some pathological changes in kidney may cause diseases. The common pregnancy-related renal injury includes gestational hypertension related renal injury, acute renal injury during pregnancy, and gestational special renal injury. As long as the chronic kidney disease (CKD) combines with pregnancy, the CKD patient's condition might be aggravated and even renal failure. This review describes renal physiology characteristics, common pregnancy-ralated renal injury and CKD combined with pregnancy, to improve the clinical treatment of gestational common renal injury.
Diabetic nephropathy is one of the most common complications of diabetes, which is a serious chronic disease to threaten human life and health. If without good treatment it may develop to the end stage renal disease (ESRD) and require renal replacement therapy. Based on domestic and foreign literature in recent years, this review describes the diabetic nephropathy diagnosis and its treatment.
Intradialytic hypotension (IDH) is one of the most common complications during hemodialysis, which is an independent risk factor of death in dialysis patients. The prevention and treatment of IDH are clinically important to improve the life quality and survival rate of hemodialysis patients. This review summarizes recent progress of the prevention and management of IDH.
Tunneled cuff catheters (TCC) have been commonly used in dialysis patients. However, this process use may cause the removal obstacles of central venous catheter due to variety of reasons, among them, stuck catheter and adhesion have been paid more attention. Stuck catheter means adhesion of the catheter to the central venous when the cuff of the TCC is separated, which may lead to removal obstacles. This stuck catheter might be due to the formation of fibrin sheath and the later calcification, which can result in more severe catheter incarceration. Usually, the TCC used over two years, or the patient with central venous stenosis may significantly increase the incidence rate of removal obstacles. This review describes common risk factors of stuck catheter, and the countermeasures for the removal obstacles of central venous catheter.
To evaluate the efficacy and safety of intravenous thrombolysis in the patients who suffered from acute ischemic stroke with unruptured cerebral aneurysms.
The clinical data of 275 acute ischemic stroke patients admitted in Changhai Hospital from September 2013 to May 2016, who received intravenous thrombolysis, were analyzed retrospectively. The 275 patients were divided into aneurysm group (n = 24) and non aneurysm group (n = 251) through CTA/MRA. The curative effect, prognosis and intracranial hemorrhage were compared between the two groups.
There was no significant difference in demographic characteristics and past medical history between two groups. There was no significant difference in efficacy and prognosis between two groups. There was no statistical difference in the intracranial hemorrhage between two groups (P>0.05).
Intravenous thrombolysis is effective and safe in patients with acute ischemic stroke accompanied by unruptured cerebral aneurysms.